Insider · CIK 0001573074

Beddingfield III Frederick

Reports to the SEC for 2 companies · CALABASAS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001573074

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+93.8K sh	—	—	93,750
2019-08-06	Sienna Biopharmaceuticals, Inc.A Award	Director, President & CEO	AAward	+150K sh	—	—	967,599
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−93.8K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−41K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−42.6K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−191K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−93.8K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+42.6K sh	—	—	42,590
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+191K sh	—	—	190,910
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+41K sh	—	—	40,968
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+93.8K sh	—	—	93,750
2019-07-02	Sienna Biopharmaceuticals, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−17.1K sh	$0.76	−$13K	817,599
2019-02-22	Sienna Biopharmaceuticals, Inc.P Purchase	Director, President & CEO	PPurchase	+40K sh	$2.50	+$100K	831,662
2019-01-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+41K sh	—	—	40,968
2019-01-01	Sienna Biopharmaceuticals, Inc.A Award	Director, President & CEO	AAward	+188K sh	—	—	791,662
2019-01-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+93.8K sh	—	—	187,500
2019-01-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+93.8K sh	—	—	93,750
2018-06-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director, President & CEO	AAward	+191K sh	—	—	190,910
2018-05-17	Sienna Biopharmaceuticals, Inc.J Other	Director, President & CEO	JOther	+47.6K sh	—	—	601,246
2017-08-01	Sienna Biopharmaceuticals, Inc.Series A-3 Preferred StockC Conversion	Director, President & CEO	CConversion	−14.1K sh	—	—	0
2017-08-01	Sienna Biopharmaceuticals, Inc.Series A-3 Preferred StockC Conversion	Director, President & CEO	CConversion	−14.1K sh	—	—	0
2017-08-01	Sienna Biopharmaceuticals, Inc.Series A-3 Preferred StockC Conversion	Director, President & CEO	CConversion	−113K sh	—	—	0
2017-08-01	Sienna Biopharmaceuticals, Inc.C Conversion	Director, President & CEO	CConversion	+14.1K sh	—	—	14,076
2017-08-01	Sienna Biopharmaceuticals, Inc.C Conversion	Director, President & CEO	CConversion	+113K sh	—	—	112,614
2017-08-01	Sienna Biopharmaceuticals, Inc.C Conversion	Director, President & CEO	CConversion	+14.1K sh	—	—	14,076
2017-07-26	Sienna Biopharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+42.6K sh	—	—	42,590
2015-10-01	KYTHERA BIOPHARMACEUTICALS INCD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−575 sh	—	—	0
2015-10-01	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−45.3K sh	—	—	0
2015-10-01	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−19.3K sh	—	—	0
2015-10-01	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−28.1K sh	—	—	0
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+13.8K sh	$44.02	+$606K	110,638
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+96.9K sh	$22.49	+$2.18M	96,875
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−111K sh	$74.91	−$8.29M	0
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−46.9K sh	—	—	28,125
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−50K sh	—	—	0
2015-09-24	KYTHERA BIOPHARMACEUTICALS INCStock OptionsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−13.8K sh	—	—	19,266
2015-06-25	KYTHERA BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−19.5K sh	$75.74	−$1.48M	0
2015-06-24	KYTHERA BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−11K sh	$75.52	−$834K	19,543
2015-06-04	KYTHERA BIOPHARMACEUTICALS INCF Tax Payment	Chief Medical Officer	FTax Payment	−9,400 sh	$53.67	−$504K	34,408
2015-06-04	KYTHERA BIOPHARMACEUTICALS INCF Tax Payment	Chief Medical Officer	FTax Payment	−3,825 sh	$54.10	−$207K	30,583
2015-04-30	KYTHERA BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−2,041 sh	$45.51	−$92.9K	43,808
2015-04-29	KYTHERA BIOPHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+5,409 sh	—	—	45,849
2015-03-23	KYTHERA BIOPHARMACEUTICALS INCF Tax Payment	Chief Medical Officer	FTax Payment	−4,790 sh	$47.50	−$228K	40,440
2015-01-29	KYTHERA BIOPHARMACEUTICALS INCCommon StockA Award	Chief Medical Officer	AAward	+45.3K sh	—	—	45,344
2015-01-29	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Chief Medical Officer	AAward	+45.3K sh	—	—	45,344
2014-03-24	KYTHERA BIOPHARMACEUTICALS INCF Tax Payment	Chief Medical Officer	FTax Payment	−4,770 sh	$40.69	−$194K	45,230
2014-01-22	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Chief Medical Officer	AAward	+33K sh	—	—	33,029
2013-04-01	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2013-04-01	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2013-04-01	KYTHERA BIOPHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Aug 84
Beddingfield III Frederick0001562180-19-004216
SEC(opens sec.gov)
Jul 34
Beddingfield III Frederick0001562180-19-003848
SEC(opens sec.gov)
Feb 264
Beddingfield III Frederick0001562180-19-001422
SEC(opens sec.gov)
Jan 34
Beddingfield III Frederick0001562180-19-000146
SEC(opens sec.gov)
Jun 44
Beddingfield III Frederick0001562180-18-002839
SEC(opens sec.gov)
May 214
Beddingfield III Frederick0001562180-18-002587
SEC(opens sec.gov)
Aug 14
Beddingfield III Frederick0001140361-17-029590
SEC(opens sec.gov)

Companies

Address

C/O KYTHERA BIOPHARMACEUTICALS 27200 WEST AGOURA ROAD, SUITE 200

CALABASAS, CA, 91301